Surgical planning tool
This article was originally published in The Gray Sheet
Belgium firm Materialise announces Sept. 17 plans for a randomized trial comparing standard X-ray-based surgical planning for wrist surgery and computer-assisted/computed tomography-based planning using the firm's 510(k)-cleared SurgiCase system. Materialise's technology or similar technology is marketed by several of the top orthopedics device firms as an add-on to their knee implant offerings (1"The Gray Sheet" Aug. 30, 2010)
You may also be interested in...
FDA's device center is warning two different orthopedic firms that the companies' personalized knee surgery instrumentation systems are being marketed without proper clearance or approval
New tendering rules in Belgium aim to improve competition between biosimilars and originators, for example by setting contract durations for tendering contracts and limiting the criteria for such contracts.
EU ministers say that implementing an appropriate fee structure that is more in line with actual costs will promote innovation in the pharmaceutical sector while ensuring “fair access” to safe and effective medicines for patients.